03:38 PM EDT, 06/16/2026 (MT Newswires) -- Healthcare stocks eased late Tuesday afternoon with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF (XLV) each decreasing 0.2%.

The iShares Biotechnology ETF (IBB) also dropped 0.2%.

In corporate news, Eli Lilly ( LLY ) acquired 4E Therapeutics, a neuroscience firm creating chronic-pain treatments. Lilly shares fell 1%.

CAMP4 Therapeutics ( CAMP ) shares jumped 6.1% after JPMorgan upgraded the stock to overweight from neutral and raised its price target to $9 from $5.

GSK (GSK) said Health Canada approved Exdensur for severe eosinophilic asthma, which is driven by elevated white blood cells, and for chronic rhinosinusitis with nasal polyps, a condition that causes blockage and inflammation. GSK shares eased 0.1%.

Oncolytics Biotech ( ONCY ) shares climbed 11% after the company received a US patent covering the pelareorep manufacturing process into 2044.